Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Pediatrics
Published in: BMC Pediatrics 1/2021

Open Access 01-12-2021 | Respiratory Syncytial Virus Infection | Research article

Identification of pathogenic genes and transcription factors in respiratory syncytial virus

Authors: Lei Li, Yong An Ni, Zhenfeng Song, Zhi Yi, Fang Wang

Published in: BMC Pediatrics | Issue 1/2021

Login to get access

Abstract

Background

Respiratory syncytial virus (RSV) is a major cause of acute lower respiratory infections in children, especially bronchiolitis. Our study aimed to identify the key genes and upstream transcription factors in RSV.

Methods

To screen for RSV pathogenic genes, an integrated analysis was performed using the RSV microarray dataset in GEO. Functional annotation and potential pathways for differentially expressed genes (DEGs) were further explored by GO and KEGG enrichment analysis. We constructed the RSV-specific transcriptional regulatory network to identify key transcription factors for DEGs in RSV.

Results

From three GEO datasets, we identified 1059 DEGs (493 up-regulated and 566 down-regulated genes, FDR < 0.05 and |Combined.ES| > 0.8) between RSV patients and normal controls. GO and KEGG analysis revealed that ‘response to virus’ (FDR = 7.13E-15), ‘mitochondrion’ (FDR = 1.39E-14) and ‘Asthma’ (FDR = 1.28E-06) were significantly enriched pathways for DEGs. The expression of IFI27, IFI44, IFITM3, FCER1A, and ISG15 were shown to be involved in the pathogenesis of RSV.

Conclusions

We concluded that IFI27, IFI44, IFITM3, FCER1A, and ISG15 may play a role in RSV. Our finding may contribute to the development of new potential biomarkers, reveal the underlying pathogenesis and also identify novel therapeutic targets for RSV.
Appendix
Available only for authorised users
Literature
1.
Lee WJ, Kim YJ, Kim DW, Lee HS, Lee HY, Kim K. Complete genome sequence of human respiratory syncytial virus genotype a with a 72-nucleotide duplication in the attachment protein G gene. J Virol. 2012;86(24):13810–1.PubMedPubMedCentralCrossRef
2.
Zhang Y, Zhuochao L. Analysis of clinical characteristics and therapy in respiratory syncytial virus acute lower respiratory infection. J Pediatr Pharmacy. 2015;21(12):15-9.
3.
Arguedasflatts YN, Capistrán MA, Christen JA, Noyola DE. An analysis of the interaction between influenza and respiratory syncytial virus based on acute respiratory infection records. arXiv e-prints. 2013:arXiv:1312.0594.
4.
Faghihloo E, Rezaie F, Salimi V, Naseri M, Mamishi S, Mahmoodi M, et al. Molecular epidemiology of human respiratory syncytial virus in Iran. Acta Virol. 2011;55(1):81–3.PubMedCrossRef
5.
Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med. 2005;171(2):137–41.PubMedCrossRef
6.
Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol. 2002;76(11):5654–66.PubMedPubMedCentralCrossRef
7.
de Steenhuijsen Piters WA, Heinonen S, Hasrat R, Bunsow E, Smith B, Suarez-Arrabal MC, et al. Nasopharyngeal microbiota, host Transcriptome, and disease severity in children with respiratory syncytial virus infection. Am J Respir Crit Care Med. 2016;194(9):1104–15.PubMedPubMedCentralCrossRef
8.
Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr. 2000;137(6):865–70.PubMedCrossRef
9.
Garcia CG, Bhore R, Soriano-Fallas A, Trost M, Chason R, Ramilo O, et al. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics. 2010;126(6):e1453–60.PubMedPubMedCentralCrossRef
10.
Madi N, Chehadeh W, Asadzadeh M, Al-Turab M, Al-Adwani A. Analysis of genetic variability of respiratory syncytial virus groups a and B in Kuwait. Arch Virol. 2018;163(9):2405–13.PubMedPubMedCentralCrossRef
11.
Cheriyath V, Leaman DW, Borden EC. Emerging roles of FAM14 family members (G1P3/ISG 6-16 and ISG12/IFI27) in innate immunity and cancer. J Interferon Cytokine Res. 2011;31(1):173–81.PubMedPubMedCentralCrossRef
12.
Martensen PM, Sogaard TM, Gjermandsen IM, Buttenschon HN, Rossing AB, Bonnevie-Nielsen V, et al. The interferon alpha induced protein ISG12 is localized to the nuclear membrane. Eur J Biochem. 2001;268(22):5947–54.PubMedCrossRef
13.
Parker N, Porter AC. Identification of a novel gene family that includes the interferon-inducible human genes 6-16 and ISG12. BMC Genomics. 2004;5(1):8.PubMedPubMedCentralCrossRef
14.
Rosebeck S, Leaman DW. Mitochondrial localization and pro-apoptotic effects of the interferon-inducible protein ISG12a. Apoptosis. 2008;13(4):562–72.PubMedCrossRef
15.
Mihalich A, Vigano P, Gentilini D, Borghi MO, Vignali M, Busacca M, et al. Interferon-inducible genes, TNF-related apoptosis-inducing ligand (TRAIL) and interferon inducible protein 27 (IFI27) are negatively regulated in leiomyomas: implications for a role of the interferon pathway in leiomyoma development. Gynecol Endocrinol. 2012;28(3):216–9.PubMedCrossRef
16.
Hsieh WL, Huang YH, Wang TM, Ming YC, Tsai CN, Pang JH. IFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes. Cell Prolif. 2015;48(2):187–97.PubMedCrossRef
17.
Li S, Xie Y, Zhang W, Gao J, Wang M, Zheng G, et al. Interferon alpha-inducible protein 27 promotes epithelial-mesenchymal transition and induces ovarian tumorigenicity and stemness. J Surg Res. 2015;193(1):255–64.PubMedCrossRef
18.
Labrada L, Liang XH, Zheng W, Johnston C, Levine B. Age-dependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12. J Virol. 2002;76(22):11688–703.PubMedPubMedCentralCrossRef
19.
Fjaerli HO, Bukholm G, Krog A, Skjaeret C, Holden M, Nakstad B. Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis. BMC Infect Dis. 2006;6:175.PubMedPubMedCentralCrossRef
20.
Hallen LC, Burki Y, Ebeling M, Broger C, Siegrist F, Oroszlan-Szovik K, et al. Antiproliferative activity of the human IFN-alpha-inducible protein IFI44. J Interferon Cytokine Res. 2007;27(8):675–80.PubMedCrossRef
21.
Hu JG, Fu Y, Xu JJ, Ding XP, Xie HQ, Li-Ling J. Altered gene expression profile in a rat model of gentamicin-induced ototoxicity and nephrotoxicity, and the potential role of upregulated Ifi44 expression. Mol Med Rep. 2017;16(4):4650–8.PubMedPubMedCentralCrossRef
22.
McDonald JU, Kaforou M, Clare S, Hale C, Ivanova M, Huntley D, et al. A simple screening approach to prioritize genes for functional analysis identifies a role for interferon regulatory factor 7 in the control of respiratory syncytial virus disease. mSystems. 2016;1(3):e00051.PubMedPubMedCentralCrossRef
23.
Bailey CC, Kondur HR, Huang IC, Farzan M. Interferon-induced transmembrane protein 3 is a type II transmembrane protein. J Biol Chem. 2013;288(45):32184–93.PubMedPubMedCentralCrossRef
24.
Everitt AR, Clare S, McDonald JU, Kane L, Harcourt K, Ahras M, et al. Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model. PLoS One. 2013;8(11):e80723.PubMedPubMedCentralCrossRef
25.
Pang J, Taylor GR, Munroe DG, Ishaque A, Fung-Leung WP, Lau CY, et al. Characterization of the gene for the human high affinity IgE receptor (Fc epsilon RI) alpha-chain. J Immunol (Baltimore, Md : 1950). 1993;151(11):6166–74.
26.
Knudson CJ, Varga SM. The relationship between respiratory syncytial virus and asthma. Vet Pathol. 2015;52(1):97–106.PubMedCrossRef
27.
Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol. 2003;5(9):834–9.PubMedCrossRef
28.
29.
Au WC, Moore PA, Lowther W, Juang YT, Pitha PM. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc Natl Acad Sci U S A. 1995;92(25):11657–61.PubMedPubMedCentralCrossRef
30.
Gonzalez-Sanz R, Mata M, Bermejo-Martin J, Alvarez A, Cortijo J, Melero JA, et al. ISG15 is Upregulated in respiratory syncytial virus infection and reduces virus growth through protein ISGylation. J Virol. 2016;90(7):3428–38.PubMedPubMedCentralCrossRef
Metadata
Title
Identification of pathogenic genes and transcription factors in respiratory syncytial virus
Authors
Lei Li
Yong An Ni
Zhenfeng Song
Zhi Yi
Fang Wang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2021
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-020-02480-4

Other articles of this Issue 1/2021

BMC Pediatrics 1/2021 Go to the issue

Research

Prevalence of urinary iodine concentration among school children: in Dessie City, Ethiopia

Research Article

Body composition in term offspring after maternal gestational diabetes does not predict postnatal hypoglycemia

Research article

NOX5 is expressed aberrantly but not a critical pathogenetic gene in Hirschsprung disease

Case report

Newborn antibodies to SARS-CoV-2 detected in cord blood after maternal vaccination – a case report

Study protocol

Advance care planning for adolescents with cancer and their parents: study protocol of the BOOST pACP multi-centre randomised controlled trial and process evaluation

Research

Mortality by opioid poisoning in children and teenagers and opioid prescriptions